Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Health Services Research|July 9, 2010
How does Medicaid-managed care impact reporting of Medicaid status?Michael R Plotzke, Jacob Alex Klerman, Michael Davern
European Urology Oncology|April 8, 2025
Suffering in Silence: Loneliness Among Men with Prostate Cancer and the Potential for Exercise as ConnectionKerri Winters-Stone, Sydnee Stoyles, Nathan F Dieckmann, et al.
Frontiers in Aging|May 4, 2026
Loneliness within couples coping with cancer: prevalence, associations with physical and mental health, and potential benefits of dyadic exerciseKerri Winters-Stone, Sydnee A Stoyles, Nathan Dieckmann, et al.
Urologic Oncology|March 9, 2010
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory resultsRenee C Prins, Brooks L Rademacher, Solange Mongoue-Tchokote, et al.
Cardiology Research|July 12, 2024
Disparity in the Under-Utilization of Novel P2Y12 Inhibitors in ST-Elevation Myocardial Infarction Following Percutaneous Coronary InterventionChad Nicholson, Maxim Zlatopolsky, Jared Steinberger, et al.
Cureus|September 1, 2022
The Relationship Between Coronary Dominance and Positive Results in Myocardial Perfusion ImagingMathhar Aldaoud, Hardik Patel, Jacob Alex, et al.
Cureus|October 14, 2021
Isolated Sub-Pulmonic Valve Endocarditis in a Patient With a History of Konno Procedure and Mechanical Aortic ValveJacob Alex, Harshil Patel, Roshni Shah, et al.
Cancer|May 19, 2016
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumorsJulie N Graff, Celestia S Higano, Noah M Hahn, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
Cancer Medicine|February 15, 2026
Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider SurveyCecilia Lacey, Khaya Clark, James Riley Debacker, et al.
Pageof 8